Levobupivacaïne Molteni

Levobupivacaine, the active ingredient in Levobupivacaïne Molteni, is a local anesthetic presented as a sterile solution for epidural use. It provides regional loss of sensation for surgical, obstetric and other procedures requiring epidural anesthesia.\n\nGNH India supplies Levobupivacaïne Molteni as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levobupivacaine is employed in regional anesthesia and analgesia for several clinical situations.\n\n- Epidural anesthesia: produces reliable sensory block for surgeries and procedures performed under regional technique.\n- Surgical anesthesia: offers dense anesthesia for operations where a regional block is preferred over general anesthesia.\n- Obstetric analgesia: provides effective pain relief during labor while preserving maternal consciousness and fetal safety.

Levobupivacaine may cause a range of adverse reactions, from mild to severe.\n\nCommon Side Effects:\n- Hypotension: reduced blood pressure following sympathetic block.\n- Bradycardia: slower heart rate due to vagal stimulation.\n- Nausea or vomiting: gastrointestinal upset after regional block.\n- Dizziness or light‑headedness: transient feeling of unsteadiness.\n- Headache: post‑dural puncture or tension‑type headache.\n\nSerious or Rare Side Effects:\n- Cardiac arrest: severe cardiotoxicity, especially with high plasma concentrations.\n- Seizures: central nervous system toxicity from excessive drug levels.\n- Respiratory depression: inadequate ventilation due to high spinal block.\n- Allergic reaction: anaphylaxis or severe skin rash.\n- Prolonged motor block: extended loss of muscle function beyond expected duration.\n- Neurotoxicity: rare peripheral nerve injury or persistent paresthesia.

Before using Levobupivacaïne Molteni, clinicians should consider several safety measures.\n\n- Cardiovascular assessment: evaluate patient’s heart rate and blood pressure prior to administration.\n- Allergy check: avoid use in individuals with known hypersensitivity to amide‑type local anesthetics.\n- Hepatic function: use caution and consider dose adjustment in patients with liver impairment.\n- Obstetric patients: monitor fetal heart rate and maternal hemodynamics closely during labor analgesia.\n- Concomitant local anesthetics: avoid mixing with other regional anesthetics to reduce systemic toxicity risk.\n- Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Levobupivacaïne Molteni can interact with other medicines, altering its safety profile.\n\nMajor Interactions (Avoid):\n- Other local anesthetics: additive systemic toxicity may occur.\n- Class I antiarrhythmic agents (e.g., quinidine): can enhance cardiotoxic effects.\n\nModerate Interactions (Monitor Closely):\n- Beta‑adrenergic blockers: may potentiate bradycardia and hypotension.\n- Calcium channel blockers: can affect cardiac conduction when combined.\n- Central nervous system depressants (e.g., benzodiazepines, opioids): may increase sedation and respiratory depression.\n- Diuretics: may exacerbate hypotensive response after epidural block.